Pathogenesis of bronchopulmonary dysplasia: an immunological perspective
- 1Department of Pediatrics, Anne Burnett Marion School of Medicine at Texas Christian University
- 2Pediatrix Medical Group of Texas — Fort Worth Neonatology
- 3Division of Neonatology, The Children’s Regional Hospital at Cooper, Cooper Medical School of Rowan University
Abstract
Bronchopulmonary dysplasia (BPD), the most common chronic lung disease of prematurity, is at its mechanistic core an immune-developmental disease in which inflammatory injury disrupts normal lung maturation. In the United States, BPD remains among the most common morbidities of very preterm birth, affecting a substantial proportion of infants born before 32 weeks’ gestation. These infants are born before alveolarization is complete, into an inflammatory environment that can impair ongoing lung development. This review advances a single thesis: the heterogeneous prenatal and postnatal insults that precede BPD (chorioamnionitis and the fetal inflammatory response syndrome, Ureaplasma colonization, hyperoxia, mechanical ventilation, sepsis, and intestinal dysbiosis) converge on a small number of innate sensing pathways, principally TLR2 and TLR4 signaling through NF-κB to the NLRP3 inflammasome — with parallel sterile inputs (mitochondrial reactive oxygen species and additional pattern-recognition receptors) feeding the same inflammasome node. We argue that this convergence is what separates BPD from ordinary neonatal lung injury, and that the outcome depends less on the magnitude of the initiating injurious hits than on failure of the resolution program that should terminate them — a hypothesis supported by convergent preclinical evidence but not yet established in preterm infants. Evidence is assembled across three domains: the cellular substrate (M1-skewed, classically activated–like alveolar macrophages, NETs, Th17/Treg imbalance, deficient transplacental IgG transfer); the mediator network (IL-1β, IL-6, IL-8, TNF-α, and the loss of endogenous brakes — specialized pro-resolving mediators, IL-37, Nrf2, short-chain fatty acids); and the signaling architecture (NF-κB, the NLRP3 inflammasome, and trained immunity). We also discuss the mechanistically supported, druggable nodes and the developmental phase in which each is engageable.
Related
- Sparse Machine Learning Pipeline with Stabl Identifies Cord Blood Multi-Omic Signatures of Bronchopulmonary Dysplasia
- MaaT013 fecal microbiotherapy modulates key gastro-intestinal and immunological processes involved in GvHD pathogenesis in vitro and in vivo
- Refractory Pseudomonas aeruginosa Bronchopulmonary Infection After Lung Transplantation for Common Variable Immunodeficiency Despite Maximal Treatment Including IgM/IgA-Enriched Immunoglobulins and Bacteriophage Therapy
- A review on applying immunological methods in animal research
- Assessment of immunological memory formation in vivo
BibTeX
@article{riley2026pathogenesis,
title = {{Pathogenesis of bronchopulmonary dysplasia: an immunological perspective}},
author = {David Riley and Vineet Bhandari},
journal = {Frontiers in Immunology},
year = {2026},
month = oct,
doi = {10.3389/fimmu.2026.1965255},
url = {https://www.frontiersin.org/articles/10.3389/fimmu.2026.1965255/full},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Pathogenesis of bronchopulmonary dysplasia: an immunological perspective
AU - David Riley
AU - Vineet Bhandari
PY - 2026
DA - 2026/10/07
JO - Frontiers in Immunology
DO - 10.3389/fimmu.2026.1965255
UR - https://www.frontiersin.org/articles/10.3389/fimmu.2026.1965255/full
AB - Bronchopulmonary dysplasia (BPD), the most common chronic lung disease of prematurity, is at its mechanistic core an immune-developmental disease in which inflammatory injury disrupts normal lung maturation. In the United States, BPD remains among the most common morbidities of very preterm birth, affecting a substantial proportion of infants born before 32 weeks’ gestation. These infants are born before alveolarization is complete, into an inflammatory environment that can impair ongoing lung development. This review advances a single thesis: the heterogeneous prenatal and postnatal insults that precede BPD (chorioamnionitis and the fetal inflammatory response syndrome, Ureaplasma colonization, hyperoxia, mechanical ventilation, sepsis, and intestinal dysbiosis) converge on a small number of innate sensing pathways, principally TLR2 and TLR4 signaling through NF-κB to the NLRP3 inflammasome — with parallel sterile inputs (mitochondrial reactive oxygen species and additional pattern-recognition receptors) feeding the same inflammasome node. We argue that this convergence is what separates BPD from ordinary neonatal lung injury, and that the outcome depends less on the magnitude of the initiating injurious hits than on failure of the resolution program that should terminate them — a hypothesis supported by convergent preclinical evidence but not yet established in preterm infants. Evidence is assembled across three domains: the cellular substrate (M1-skewed, classically activated–like alveolar macrophages, NETs, Th17/Treg imbalance, deficient transplacental IgG transfer); the mediator network (IL-1β, IL-6, IL-8, TNF-α, and the loss of endogenous brakes — specialized pro-resolving mediators, IL-37, Nrf2, short-chain fatty acids); and the signaling architecture (NF-κB, the NLRP3 inflammasome, and trained immunity). We also discuss the mechanistically supported, druggable nodes and the developmental phase in which each is engageable.
SN - 1664-3224
ER -